A period date, a pregnancy test result, a medication change or a note that sex was painful can seem like small pieces of information. Together, they can describe parts of life that many women have been taught to minimise or keep private. That is why women's health data privacy trends matter. The question is not whether you should pay attention to your body. You are not dramatic for noticing patterns, or for wanting a record that helps you speak clearly at an appointment. The question is who can see that record, what they can do with it, and whether you were given a real choice.
Privacy is not a decorative setting at the bottom of a health app. It is part of whether people feel safe enough to record what is happening in their bodies at all.
Reproductive health data is being recognised as its own category
For years, digital health privacy was discussed as one broad category. That is changing. Menstrual, fertility, pregnancy, sexual health and IVF-related information are increasingly recognised as especially sensitive because they can reveal intimate facts even when an app does not ask a direct question. A cycle record may suggest a missed period or fertility treatment timing; symptom entries can reveal pelvic pain, mood changes, miscarriage or medication side effects. No single field tells the whole story, but patterns can.
In the UK, this information is generally treated as special category personal data under UK GDPR. In South Africa, it is classified as special personal information under POPIA. These frameworks place stronger duties on organisations, but legal protection is not the same as clarity, and a policy can meet the letter of the law while still leaving a reader unsure what actually happens to her data. The trend worth watching is a growing expectation that services explain their choices plainly, ask for meaningful consent, and collect only what they genuinely need.
Consent is moving beyond the tick box
Many people have clicked "agree" while trying to get through registration quickly. That does not mean they have understood what follows. Better privacy practice separates different decisions rather than bundling them into one broad permission, and this is the shift worth watching most closely.
You may be comfortable with an app using your entries to show your own history, but not with those entries being used to train an AI system. You may want a linked clinician to see symptoms and medications between appointments, but not want data shared with third-party analytics providers. Those are different purposes and, in good design, should be presented as genuinely different choices rather than one switch that covers everything.
This matters particularly where AI is involved. An AI companion may be useful for helping someone understand general health information or prepare questions for an appointment. But a responsible service should say plainly what information the system receives, whether conversations are retained, whether they are used to improve the system, and what human oversight exists. Vague statements about "improving your experience" are not enough when the subject is reproductive health, and treating AI training as its own explicit, separable choice, rather than folded into a general terms-of-service tick, is exactly the direction better practice is moving.
Consent also has limits. In a clinical setting, some data processing may be necessary to deliver care or meet record-keeping obligations, which is different from asking permission to use identifiable information for optional research or marketing. If a service cannot explain that difference in ordinary language, it has not earned trust.
De-identified data is useful, but not risk-free
Another major trend is the increased use of aggregated and de-identified health data for research, service planning and software development. There is real public value here: large, carefully governed datasets can help researchers study gaps in care or recognise patterns in symptoms.
But "de-identified" is not a magic word. Removing a name does not always remove the possibility of re-identification, especially when a dataset contains detailed dates, locations, rare conditions or a distinctive combination of events. The more granular the record, the more useful it may be for research, and the more carefully it needs to be protected. A good question is not simply, "Do you anonymise data?" Ask how. Is it aggregated? Are direct identifiers removed? Who can access it? Is it sold, licensed or shared? Can you opt out where the use is not necessary for your own care?
The UK Information Commissioner's Office has repeatedly stressed that anonymisation is a process, not a permanent label, precisely because the risk of re-identification has to be actively assessed and reduced, not declared once and forgotten.
Where Feminal sits in this shift
Feminal treats the consent-unbundling trend described above as a starting design decision rather than an afterthought. Recording your cycle, symptoms and medications so a linked clinician can see them between appointments is one choice, made through pairing, entirely within your control. Your conversations with Alina, the in-app companion, being used to train AI models is a separate question, and the answer is simply no, not a setting buried somewhere to opt out of. That is what treating these as genuinely different decisions looks like in practice, rather than as a policy statement.
For the fuller practical checklist, our companion articles on protecting your reproductive health data, and on choosing a menstrual-tracking app specifically, cover device security, account safety and exactly what to ask before you connect a clinician. This article is about the direction the industry is moving; those are about what to do with that today.
When a privacy question should not delay care
Attention to your privacy should never come at the cost of attention to a symptom that needs care. Seek urgent medical help for severe or worsening symptoms, heavy bleeding with concerning signs, or pain in early pregnancy. If you are worried that something is seriously wrong, seek immediate medical care rather than waiting for an app, or a privacy decision, to provide reassurance.
Your health record should not require you to choose between being informed and being private. You deserve both: enough detail to be taken seriously, and enough control to decide who is invited into the conversation.
Sources used
UK GDPR provisions on special category data. South Africa's Protection of Personal Information Act (POPIA) on special personal information. UK Information Commissioner's Office guidance on anonymisation. HFEA standards for licensed fertility clinics.